Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             227 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A broad spectrum phase II trial with continuous infusion (CI) of recombinant interleukin-2 (IL-2) in metastatic tumors Le Ceane, A
 1993
 29 Supplement 2 p. S47-
1 p.
 artikel
2 A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumours Prévost, Grégoire
 1993
 29 Supplement 2 p. 1589-1592
4 p.
 artikel
3 Activity of cisplatin in adenocarcinoma of the pancreas Wils, J.A.
 1993
 29 Supplement 2 p. 203-204
2 p.
 artikel
4 Adjuvant chemotherapy with a nitrosourea-based protocol in advanced malignant melanoma Karakousis, C.
 1993
 29 Supplement 2 p. 1831-1835
5 p.
 artikel
5 Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre study Bakkevold, K.E.
 1993
 29 Supplement 2 p. 698-703
6 p.
 artikel
6 Adopive immunotherapy with interleukin-2 (IL2) + interferon (αIFN) + IL2-activated lymphocytes (LAK) in metastatic renal cell cancer Goey, S.H.
 1993
 29 Supplement 2 p. S48-
1 p.
 artikel
7 Advances in systemic treatment of malignant melanoma Aapro, Matti S.
 1993
 29 Supplement 2 p. 613-617
5 p.
 artikel
8 Alteration of the proto-oncogene HER2/neu in correlation to the clinical pathological factors in gastrointestinal adenocarcinoma Ben-Aharon, U
 1993
 29 Supplement 2 p. S196-
1 p.
 artikel
9 An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer Khan, Seema A.
 1993
 29 Supplement 2 p. 1686-1690
5 p.
 artikel
10 Antimetastatic effect of tumor irradiation and r-IL-2 on lung metastases in the rat Eljuga, D
 1993
 29 Supplement 2 p. S51-
1 p.
 artikel
11 A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours Bokemeyer, C.
 1993
 29 Supplement 2 p. 2225-2231
7 p.
 artikel
12 A phase II study of continuous intravenous infusion (CIVI) recombinant IL-2 and subcutaneous α-interferon by sequential administration in advanced renal cell cancer Besana, C
 1993
 29 Supplement 2 p. S50-
1 p.
 artikel
13 A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer Levine, Mark N.
 1993
 29 Supplement 2 p. 37-43
7 p.
 artikel
14 A prognostic index in patients with metastatic or recurrent transitional cell carcinoma of the urothelium (TCU) Sengeløv, L
 1993
 29 Supplement 2 p. S229-
1 p.
 artikel
15 A randomised cross-over trial of antiemetic therapy for platinum-based chemotherapy. Improved control with an intensive multiagent regimen Findlay, Michael
 1993
 29 Supplement 2 p. 309-315
7 p.
 artikel
16 A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis Warr, David
 1993
 29 Supplement 2 p. 33-36
4 p.
 artikel
17 A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder Witjes, J.A.
 1993
 29 Supplement 2 p. 1672-1676
5 p.
 artikel
18 A single-centre experience with continuous intravenous infusion of recombinant interleukin-2 ± lak cells in metastatic renal cell cancer Besana, C
 1993
 29 Supplement 2 p. S50-
1 p.
 artikel
19 Aspects of surgery in ovarian and endometrial carcinoma Aalders, J.G.
 1993
 29 Supplement 2 p. 624-628
5 p.
 artikel
20 Assessment of quality of life during second line chemotherapy for advanced breast cancer Voest, E.E.
 1993
 29 Supplement 2 p. S85-
1 p.
 artikel
21 Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer Schor, A.M.
 1993
 29 Supplement 2 p. 1141-1145
5 p.
 artikel
22 Association of lytic effector cell function with high expression of HER-2 expression in breast cancer patients Wiltschke, C.
 1993
 29 Supplement 2 p. S64-
1 p.
 artikel
23 A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours Mousseau, M.
 1993
 29 Supplement 2 p. 753-759
7 p.
 artikel
24 Bilateral testicular tumours: Prevalence and clinical implications Bokemeyer, Carsten
 1993
 29 Supplement 2 p. 874-876
3 p.
 artikel
25 Biochemotherapy with dtic and thymosin-α1 (TA1) + interleukin-2 (IL-2) in patients (PTS) with metastatic melanoma (MM) Carpano, S
 1993
 29 Supplement 2 p. S182-
1 p.
 artikel
26 Black (air-cured) and blond (flue-cured) tobacco cancer risk IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens Bartsch, H.
 1993
 29 Supplement 2 p. 1199-1207
9 p.
 artikel
27 Bone involvement in childhood Hodgkin's disease Büyükpamukçu, M
 1993
 29 Supplement 2 p. S170-
1 p.
 artikel
28 Breast cancer and osteoporosis—A bridge at last Fentiman, I.S.
 1993
 29 Supplement 2 p. 485-486
2 p.
 artikel
29 Breast cancer associated brachial plexopathy: Still a diagnostic and treatment challange Merimsky, O.
 1993
 29 Supplement 2 p. S59-
1 p.
 artikel
30 Breast conserving therapy in patients with relatively large (T2, T3) breast cancers by preoperative irradiation and myocutaneous LD flap reconstruction. A new technique in breast conservation Zoetmulder, F.A.N.
 1993
 29 Supplement 2 p. 957-961
5 p.
 artikel
31 CA 15.3 determination in patients with breast cancer: Clinical utility for the detection of distant metastases Bombardieri, Emilio
 1993
 29 Supplement 2 p. 144-146
3 p.
 artikel
32 Cancer incidence in the Commonwealth of Independent States, the Baltic States and Georgia—The former U.S.S.R. Zaridze, David G.
 1993
 29 Supplement 2 p. 1609-1620
12 p.
 artikel
33 Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer Groen, H.J.M.
 1993
 29 Supplement 2 p. 1696-1699
4 p.
 artikel
34 CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery Yedema, C.A.
 1993
 29 Supplement 2 p. 966-971
6 p.
 artikel
35 CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells Abbasi, A.M.
 1993
 29 Supplement 2 p. 1995-2002
8 p.
 artikel
36 Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: Its prognostic value on short-term recurrences Gaglia, Piero
 1993
 29 Supplement 2 p. 1509-1513
5 p.
 artikel
37 C-erbB-2/HER-2 protein in human intracranial tumours Torp, Sverre Helge
 1993
 29 Supplement 2 p. 1604-1606
3 p.
 artikel
38 Chemoimmunotherapy of metastatic malignant melanoma The Salpétrière Hospital (SOMPS) experiences Khayat, D.
 1993
 29 Supplement 2 p. S2-S5
4 p.
 artikel
39 Chemoprevention 1993
 29 Supplement 2 p. 648-
1 p.
 artikel
40 Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer Reyno, Leonard M.
 1993
 29 Supplement 2 p. 21-23
3 p.
 artikel
41 Clinical heterogeneity of hereditary breast cancer and its impact on screening protocols: The dutch experience on 24 families under surveillance Vasen, H.F.A.
 1993
 29 Supplement 2 p. 1111-1114
4 p.
 artikel
42 Clinical results after doxorubicin extravasation treated with excision guided by fluorescence microscopy Andersson, Anders P.
 1993
 29 Supplement 2 p. 1712-1714
3 p.
 artikel
43 Clonogenic potential of myeloid leukaemia cells in vitro is restricted to leukaemia cells expressing the CD34 antigen Yin, Moying
 1993
 29 Supplement 2 p. 2279-2283
5 p.
 artikel
44 Colon cancer in seven siblings Ghadirian, Parviz
 1993
 29 Supplement 2 p. 1553-1556
4 p.
 artikel
45 Combination chemoimmunotherapy for metastatic colorectal cancer using 5-fluorouracil, leucovorin and interleukin-2 Yang, James C.
 1993
 29 Supplement 2 p. 355-359
5 p.
 artikel
46 Combination IL-2 and cisplatinum: a promising treatment for bronchioloalveolar carcinoma? Trillet-Lenoir, V.
 1993
 29 Supplement 2 p. 1917-1918
2 p.
 artikel
47 Combination of interleukin-2 and gamma interferon in metastatic renal cell carcinoma Escudier, B.
 1993
 29 Supplement 2 p. 724-728
5 p.
 artikel
48 Combined antineoplastic and antiretroviral theraphy for patients with Hodgkin's disease and HIV infection (HD-HIV): A prospective study in 17 patients Tirelli, U.
 1993
 29 Supplement 2 p. S168-
1 p.
 artikel
49 Combined modality therapy for stage IIIA non-small cell carcinoma of the lung Weitberg, Alan B.
 1993
 29 Supplement 2 p. 511-515
5 p.
 artikel
50 Comparative pharmacological, toxicological and antitumoral evaluation of free and liposome-encapsulated cisplatin in rodents Gondal, Javed A
 1993
 29 Supplement 2 p. 1536-1542
7 p.
 artikel
51 Conformal therapy: Potential gains and pitfalls Bartelink, H.
 1993
 29 Supplement 2 p. S28-
1 p.
 artikel
52 Continuous intravenous interleukin-2 infusion and subcutaneous interferon-α in metastatic renal cell carcinoma Fosså, Sophie D.
 1993
 29 Supplement 2 p. 1313-1315
3 p.
 artikel
53 Correlation of morphological FAB classification and immunophenotyping: Value in recognition of morphological, cytochemical and immunological characteristics of mixed leukaemias Boban, Dubravka
 1993
 29 Supplement 2 p. 1167-1172
6 p.
 artikel
54 Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns Merlo, Adrian
 1993
 29 Supplement 2 p. 2118-2125
8 p.
 artikel
55 Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent cultures Pizao, Paulo E.
 1993
 29 Supplement 2 p. 1566-1573
8 p.
 artikel
56 3′-Deamino-3′-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): A new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicity Danesi, Romano
 1993
 29 Supplement 2 p. 1560-1565
6 p.
 artikel
57 Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months Ejlertsen, B.
 1993
 29 Supplement 2 p. 527-531
5 p.
 artikel
58 Delayed emesis following high-dose cisplatin: A double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo Gandara, D.R.
 1993
 29 Supplement 2 p. S35-S38
4 p.
 artikel
59 Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts Ruiz van Haperen, Veronique W.T.
 1993
 29 Supplement 2 p. 2132-2137
6 p.
 artikel
60 Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: Results of three consecutive phase II studies Bosset, J.F
 1993
 29 Supplement 2 p. 1406-1410
5 p.
 artikel
61 Dihydropyrimidine dehydrogenase activity in cancer patients Milano, G.A.
 1993
 29 Supplement 2 p. 740-744
5 p.
 artikel
62 Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6 Lennette, Evelyne T.
 1993
 29 Supplement 2 p. 1584-1589
6 p.
 artikel
63 EACR-12 in Brussels Price, Michael R.
 1993
 29 Supplement 2 p. 1790-1791
2 p.
 artikel
64 Effect of dequalinium on K1735-M2 melanoma cell growth, directional migration and invasion in vitro Helige, Christine
 1993
 29 Supplement 2 p. 124-128
5 p.
 artikel
65 Effect of d,l-verapamil, verapamil enantiomers and verapamil metabolites on the binding of vincristine to α1-acid glycoprotein Woodcock, B.G.
 1993
 29 Supplement 2 p. 559-561
3 p.
 artikel
66 Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II) Brünner, N.
 1993
 29 Supplement 2 p. 562-569
8 p.
 artikel
67 Effect of liposomal allogeneic melanoma vaccine with IL-2 on cellular immune responses Adler, A.
 1993
 29 Supplement 2 p. S48-
1 p.
 artikel
68 Effect of salt on carcinogen penetration to proliferative cells in the rat gastric mucosa Sørbye, H
 1993
 29 Supplement 2 p. S88-
1 p.
 artikel
69 Effect of whole body hyperthermia on Cis-diamminechloroplatinum (II)-induced antitumour activity and tissue pt-distribution: Do anaesthetics influence the therapeutic ratio? Wondergem, J.
 1993
 29 Supplement 2 p. 549-554
6 p.
 artikel
70 Effects of different culture protocols on the expression of discrete T-cell receptor variable regions in human tumour infiltrating lymphocytes Filgueira, Luis
 1993
 29 Supplement 2 p. 1754-1760
7 p.
 artikel
71 Emesis related to chemotherapy: a survey Nieweg, M.B.
 1993
 29 Supplement 2 p. S263-
1 p.
 artikel
72 Evidence of EBV DNA and adenovirus 2 E1A (Types 2 and 5) in the mucous membrane of bromchial carcinoma and pleuramesothelioma Rüther, U.
 1993
 29 Supplement 2 p. S89-
1 p.
 artikel
73 Evidence of post-translational regulation of P-glycoprotein associated with the expression of a distinctive multiple drug-resistant phenotype in Chinese hamster ovary cells McClean, Siobhán
 1993
 29 Supplement 2 p. 2243-2248
6 p.
 artikel
74 Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer Lipponen, P.
 1993
 29 Supplement 2 p. 749-753
5 p.
 artikel
75 Expression of P-glycoprotein in relation to clinical manifestation, treatment and prognosis of adrenocortical cancer Haak, H.R.
 1993
 29 Supplement 2 p. 1036-1038
3 p.
 artikel
76 Feasibility study of high dose ifosfamide (I) plus cisplatin (C) combined with rh-GCSF every 2 weeks in advanced solid tumors Planting, A.
 1993
 29 Supplement 2 p. S56-
1 p.
 artikel
77 First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer Bafaloukos, D.
 1993
 29 Supplement 2 p. 851-853
3 p.
 artikel
78 Fluorouracil, epirubicin, cyclophosphamide (FEC) primary chemotherapy to avoid mastectomy in operable breast cancer Pedrazzoli, P.
 1993
 29 Supplement 2 p. S73-
1 p.
 artikel
79 Folinic acid, 5-fluorouracil bolus and infusion and mitoxantrone with or without cyclophosphamide in metastatic breast cancer Louvet, Christophe
 1993
 29 Supplement 2 p. 1835-1838
4 p.
 artikel
80 HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples Hruza, Christa
 1993
 29 Supplement 2 p. 1593-1597
5 p.
 artikel
81 High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study Ibrahim, Amad
 1993
 29 Supplement 2 p. 1398-1403
6 p.
 artikel
82 High-dose epirubicin (HD-E) in a 2-week (W) schedule in advanced breast cancer (ABC) Ries, F.
 1993
 29 Supplement 2 p. S82-
1 p.
 artikel
83 HLA expression on tumor cells and serum levels of soluble IL-2 receptor in colorectal cancer Torlone, N.
 1993
 29 Supplement 2 p. S99-
1 p.
 artikel
84 Hormonal therapy for metastatic renal cell carcinoma combined androgen and provera followed by high dose tamoxifen Papac, R.J.
 1993
 29 Supplement 2 p. 997-999
3 p.
 artikel
85 How cost-effective is breast cancer screening in different EC countries? van Ineveld, B.Martin
 1993
 29 Supplement 2 p. 1663-1668
6 p.
 artikel
86 Ifosfamide plus carboplatin for the treatment of advanced head and neck cancer. Preliminary report Cervellino, J.C.
 1993
 29 Supplement 2 p. S141-
1 p.
 artikel
87 Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens Nouri, A.M.E.
 1993
 29 Supplement 2 p. 1895-1899
5 p.
 artikel
88 Immunological reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation for advanced ovarian cancer Scambia, Giovanni
 1993
 29 Supplement 2 p. 1518-1522
5 p.
 artikel
89 Importance of the irradiation timing within a chemoradiotherapy sequence including cisplatin and 5-FU-folinic acid. Experimental results Lagrange, J.L.
 1993
 29 Supplement 2 p. 1531-1535
5 p.
 artikel
90 Improvement in the prognostic value of nuclear components of cytological-histological MSBR grading and its dependent relationship to ploidy and S-phase status in primary operable breast carcinoma Le Doussal, V
 1993
 29 Supplement 2 p. S58-
1 p.
 artikel
91 Incidence of second primary cancer following testicular cancer Møller, H.
 1993
 29 Supplement 2 p. 672-676
5 p.
 artikel
92 Increasing survival of patients with urinary bladder cancer. A nationwide study in sweden 1960–1986 Malmström, Per-Uno
 1993
 29 Supplement 2 p. 1868-1872
5 p.
 artikel
93 Indication and limits of megatherapy and bone marrow transplantation in high-risk neuroblastoma: A single centre analysis of prognostic factors Philip, T.
 1993
 29 Supplement 2 p. 947-956
10 p.
 artikel
94 Inhibition of human breast cancer cell growth by N-(4-hydroxyphenyl) retinamide and 13-cis-retinoic acid alone and in combination with tamoxifen Lama, G
 1993
 29 Supplement 2 p. S122-
1 p.
 artikel
95 In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment Vitolo, Domenico
 1993
 29 Supplement 2 p. 371-377
7 p.
 artikel
96 Insulin-like growth factor-I-dependent growth and in vitro chemosensitivity of Ewing's sarcoma and peripheral primitive neuroectodermal tumour cell lines Hofbauer, Susanne
 1993
 29 Supplement 2 p. 241-245
5 p.
 artikel
97 Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumour Zumkeller, Walter
 1993
 29 Supplement 2 p. 1973-1977
5 p.
 artikel
98 Interleukin-2 and interferon in advanced renal and ovarian cancer Selby, P.
 1993
 29 Supplement 2 p. S15-
1 p.
 artikel
99 Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer Atzpodien, Jens
 1993
 29 Supplement 2 p. S6-S8
3 p.
 artikel
100 Interleukin-2 intravesical continuous perfusion in the prevention of post tur relapse of operated superficial bladder cancer Ferlazzo, G.
 1993
 29 Supplement 2 p. S232-
1 p.
 artikel
101 Intestinal radiation damage after radiotherapy and chemotherapy (experiment on dogs) Lukič, F.
 1993
 29 Supplement 2 p. S94-
1 p.
 artikel
102 Intraoperative brachytherapy in the treatment of soft tissue sarcomas Cionini, L.
 1993
 29 Supplement 2 p. S185-
1 p.
 artikel
103 Intravesical mitoxantrone in superficial bladder tumours (Ta-T1) Serretta, Vincenzo
 1993
 29 Supplement 2 p. 1899-1900
2 p.
 artikel
104 In vitro and in vivo antitumoral activity of alkylphosphonates Ries, Uwe J.
 1993
 29 Supplement 2 p. 96-101
6 p.
 artikel
105 In vitro prediction of cytostatic drug resistance in primary cell cultures of solid malignant tumours Dietel, Manfred
 1993
 29 Supplement 2 p. 416-420
5 p.
 artikel
106 In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancer Lissoni, P.
 1993
 29 Supplement 2 p. 1127-1132
6 p.
 artikel
107 In vivo kinetic study and biodistribution of Tc-99m-F(ab′)2 of antimelanoma antibody Sergieva, S.
 1993
 29 Supplement 2 p. S180-
1 p.
 artikel
108 Kvaluation of the phagocytosis during subcutanrous recombinant IL-2 treatment Abbate, I
 1993
 29 Supplement 2 p. S51-
1 p.
 artikel
109 Laser surgery for small perianal neoplasms Bandieramonte, Gaetano
 1993
 29 Supplement 2 p. 1528-1531
4 p.
 artikel
110 Lipid-bound sialic acid, prostaglandin e and histamine in head and neck cancer Klapan, Ivica
 1993
 29 Supplement 2 p. 839-845
7 p.
 artikel
111 Long-term analysis of patients with Ewing's sarcoma (ES) surviving, progression-free, longer than 3 years Lombardi, F.
 1993
 29 Supplement 2 p. S197-
1 p.
 artikel
112 Long term effects of tamoxifen Cuzick, J.
 1993
 29 Supplement 2 p. 15-21
7 p.
 artikel
113 Long term results of treatment in patients with extragonadal germ cell tumours Gutierrez Delgado, F.
 1993
 29 Supplement 2 p. 1002-1005
4 p.
 artikel
114 Low-dose dopamine induces early recovery of recombinant interleukin-2—Impaired renal function Palmieri, G.
 1993
 29 Supplement 2 p. 1119-1122
4 p.
 artikel
115 Metabolic response of AH13r rat tumours to cyclophosphamide as monitored by pO2 and pH semi-microelectrodes Jähde, Eckhard
 1993
 29 Supplement 2 p. 116-122
7 p.
 artikel
116 Mitoxantrone, folinic acid, 5-fluorouracil and prednisone as first-line chemotherapy for advanced breast carcinoma. A phase II study Carmo-Pereira, J.
 1993
 29 Supplement 2 p. 1814-1816
3 p.
 artikel
117 Mitoxantrone, leucovorin and high-dose infusional 5-fluorouracil: an effective and wellttolerated regimen for the treatment of advanced breast cancer Wils, J.A.
 1993
 29 Supplement 2 p. 2106-2108
3 p.
 artikel
118 Modulation of tumor growth, angiogenesis and metastatic capacity by heparin-like molecules Vlodavsky, I.
 1993
 29 Supplement 2 p. S11-
1 p.
 artikel
119 Molecular basis of the cellular response to ionizing radiation Powell, Simon
 1993
 29 Supplement 2 p. S5-
1 p.
 artikel
120 Molecular cloning of IGFBP-5 from SCLC cell lines and expression of IGFBP-4, IGFBP-5 and IGFBP-6 in lung cancer cell lines and primary tumours Wegmann, Barbara R
 1993
 29 Supplement 2 p. 1578-1584
7 p.
 artikel
121 Morbidity of combined surgery and interstitial and external beam radiotherapy in soft tissue sarcoma with poor prognosis and recurrent fibromatosis Wijnmaalen, A.J.
 1993
 29 Supplement 2 p. S184-
1 p.
 artikel
122 MTP-PE in liposomes as post-operative adjuvant therapy for colon cancer (Dukes' C): A pilot adjuvant phase II trial Frohmüller, S
 1993
 29 Supplement 2 p. S93-
1 p.
 artikel
123 Neuroblastoma: A multiple biological disease Tonini, Gian Paolo
 1993
 29 Supplement 2 p. 802-804
3 p.
 artikel
124 Neuroimmunomodulation(NIM) and IL-2 immunotherapy: A neuroe ndocrine combination with IL-2 and melatonin(MLT) in advan ced solid tumors Lissoni, P.
 1993
 29 Supplement 2 p. S48-
1 p.
 artikel
125 Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: Preliminary results Lissoni, P
 1993
 29 Supplement 2 p. 185-189
5 p.
 artikel
126 Neuron-specific enolase in cerebrospinal fluid of patients with metastatic and non-metastatic neurological disease Beelen, Nathalie A.A.
 1993
 29 Supplement 2 p. 193-195
3 p.
 artikel
127 Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration Caraceni, A.
 1993
 29 Supplement 2 p. 1266-1269
4 p.
 artikel
128 Neurotoxicity following weekly therapy with folinic acid and high-dose 5-fluorouracil 24-h infusion in patients with gastrointestinal malignancies Weh, Hans Josef
 1993
 29 Supplement 2 p. 1218-1219
2 p.
 artikel
129 “Occult” papillary carcinoma of the thyroid: a questionable entity Salvadori, Bruno
 1993
 29 Supplement 2 p. 1817-1820
4 p.
 artikel
130 Ondansetron Roila, Fausto
 1993
 29 Supplement 2 p. S16-S21
6 p.
 artikel
131 On the influence of alpha-2 interferon (roferon-a) on remission duration in patients with stages III and IV low grade malignant non-Hodgkin's lymphoma Meerwaldt, J.H.
 1993
 29 Supplement 2 p. S173-
1 p.
 artikel
132 2. Organisation of the programme 1993
 29 Supplement 2 p. S5-S8
4 p.
 artikel
133 Patient administration management system (PAMS) A preliminary report Jongkind, H
 1993
 29 Supplement 2 p. S258-
1 p.
 artikel
134 Patient documentation as an essential tool for quality assurance in the management of breast cancer Vantongelen, K.
 1993
 29 Supplement 2 p. S41-
1 p.
 artikel
135 Patients as subjects of experiments, the nurse's role? Rasmussen, A.
 1993
 29 Supplement 2 p. S256-
1 p.
 artikel
136 Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients de Forni, M.
 1993
 29 Supplement 2 p. 983-988
6 p.
 artikel
137 Phase I II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer Buter, Jan
 1993
 29 Supplement 2 p. 2108-2113
6 p.
 artikel
138 Phase I–II study of the addition of α-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of α-2a interferon and leucovorin Sinnige, Harm A.M.
 1993
 29 Supplement 2 p. 1715-1720
6 p.
 artikel
139 Phase II study of cystemustine in metastatic colorectal carcinoma Kerbrat, P.
 1993
 29 Supplement 2 p. 1597-1599
3 p.
 artikel
140 Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients Jassem, J.
 1993
 29 Supplement 2 p. 1720-1722
3 p.
 artikel
141 Phase II study of weekly administration of vinorelbine in heavily pretreated Hodgkin's disease Devizzi, L.
 1993
 29 Supplement 2 p. S171-
1 p.
 artikel
142 Phase II trial of adding reconsinant alfa-2 interferon (IFN) (intron AR) for progressive lung metastases in patients with advanced colorectal cancer (CRC) pretreated with 5-fluorouracil (5-FU) and leucovorin (LV) Görg, C
 1993
 29 Supplement 2 p. S97-
1 p.
 artikel
143 Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung Cappelaere, P.
 1993
 29 Supplement 2 p. 1216-
1 p.
 artikel
144 Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer Gridelli, Cesare
 1993
 29 Supplement 2 p. 1729-1731
3 p.
 artikel
145 Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells Schwartz-Albiez, R.
 1993
 29 Supplement 2 p. 1184-1189
6 p.
 artikel
146 Ploidy and proliferative index in medulloblastoma: Useful prognostic factors? Tait, Diana M.
 1993
 29 Supplement 2 p. 1383-1387
5 p.
 artikel
147 Poor prognosis associated with elevated serum CA 19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF Kouri, Mauri
 1993
 29 Supplement 2 p. 1691-1696
6 p.
 artikel
148 Possible biological mechanisms for a relationship between vasectomy and prostatic cancer Howards, S.S.
 1993
 29 Supplement 2 p. 1060-1062
3 p.
 artikel
149 Potential contribution of 131I-Labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: Pretherapeutic study with dose recovery in resected tissues Ychou, Marc
 1993
 29 Supplement 2 p. 1105-1111
7 p.
 artikel
150 Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents Vogel, M
 1993
 29 Supplement 2 p. 2009-2014
6 p.
 artikel
151 Predicting potential of c-erbB-2 orcoprotein and laminin receptor expression on primary breast cancer Coinaghi, M.I.
 1993
 29 Supplement 2 p. S31-
1 p.
 artikel
152 Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumours Droz, Jean-Pierre
 1993
 29 Supplement 2 p. 818-821
4 p.
 artikel
153 Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma Sweetenham, John W.
 1993
 29 Supplement 2 p. 190-192
3 p.
 artikel
154 Prevention of emesis by ics 205-930 in children receiving cytotoxic chemotherapy Hachimi-Idrissi, S.
 1993
 29 Supplement 2 p. 854-856
3 p.
 artikel
155 Prognostic factors in esophageal carcinoma Siewert, J.R.
 1993
 29 Supplement 2 p. S29-
1 p.
 artikel
156 Progress in our understanding of the genetics of breast cancer Timothy, Bishop D
 1993
 29 Supplement 2 p. S14-
1 p.
 artikel
157 Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer Bajetta, Emilio
 1993
 29 Supplement 2 p. 1658-1663
6 p.
 artikel
158 Pulmonary morbidity 10–18 years after irradiation for Hodgkin's disease Hassink, Elly A.M.
 1993
 29 Supplement 2 p. 343-347
5 p.
 artikel
159 Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS) Hollen, Patricia J.
 1993
 29 Supplement 2 p. S51-S58
8 p.
 artikel
160 Radioimmunoscintigraphy using [111In]antimyosin Fab fragments for the diagnosis and follow-up of rhabdomyosarcoma Hoefnagel, C.A.
 1993
 29 Supplement 2 p. 2096-2100
5 p.
 artikel
161 Radiotherapy in retinoblastoma: Indications, techniques, results and future considerations Mirimanoff, R.O.
 1993
 29 Supplement 2 p. S26-
1 p.
 artikel
162 Radiotherapy of nasopharyngeal carcinoma (NPC). Is prophylactic neck irradiation necessary? Mestre, M.
 1993
 29 Supplement 2 p. S140-
1 p.
 artikel
163 Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy Trillet-Lenoir, V.
 1993
 29 Supplement 2 p. 319-324
6 p.
 artikel
164 Recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer Mori, Kiyoshi
 1993
 29 Supplement 2 p. 677-680
4 p.
 artikel
165 Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer—A phase I toxicity study and pharmacokinetic analysis Prendiville, J.
 1993
 29 Supplement 2 p. 1700-1707
8 p.
 artikel
166 Recombinant interleukin-2 (RIL-2) + interferon (IFN)- alpha2b in the outpatient clinic treatment of metastatic renal cell carcinoma (MRC) Santoro, A.
 1993
 29 Supplement 2 p. S234-
1 p.
 artikel
167 Reconstitution of recombinant interleukin-2 (rIL-2): a comparative study of various rIL-2 muteins Vlasveld, Lodewijk Th.
 1993
 29 Supplement 2 p. 1977-1979
3 p.
 artikel
168 Reduction of doxorubicin-induced cardiotoxicity in the rat by the use of a N-(2-hydroxypropyl) methacrylamide dose delivery system Hopewell, J.W.
 1993
 29 Supplement 2 p. S121-
1 p.
 artikel
169 Regional lung cancer death rates unrelated to smoking? The case of The Netherlands Kunst, Anton E.
 1993
 29 Supplement 2 p. 270-273
4 p.
 artikel
170 Regional therapy of melanoma Lejeune, F.J.
 1993
 29 Supplement 2 p. 606-612
7 p.
 artikel
171 Regulation of insulin-like growth factor binding proteins in ovarian cancer cells by oestrogen Krywicki, Robert F.
 1993
 29 Supplement 2 p. 2015-2019
5 p.
 artikel
172 Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity Nicholson, R.I.
 1993
 29 Supplement 2 p. 1018-1023
6 p.
 artikel
173 Resection of colorectal liver metastases Ekberg, H.
 1993
 29 Supplement 2 p. S44-
1 p.
 artikel
174 Response of a cancer registry to reports of disease clusters King, Will D.
 1993
 29 Supplement 2 p. 1414-1418
5 p.
 artikel
175 Response of soluble IL-2 receptor levels to repeated cycles of IL-2 immunotherapy/chemotherapy Spiers, E.M.
 1993
 29 Supplement 2 p. 928-
1 p.
 artikel
176 Results of a phase-II study of combination treatment of patients with metastatic hypernephroma with recombinant interferon-alpha and interleukin-2 Morant, R.
 1993
 29 Supplement 2 p. S233-
1 p.
 artikel
177 Results of a phase II study using MIP regimen (Mitomycin+ifosfamide+Cisplatin) in unresectable Non Small Cell Lung Cancer Dutin, J.P.
 1993
 29 Supplement 2 p. S165-
1 p.
 artikel
178 Retinoids in the treatment of neuroblastoma Lie, S.O.
 1993
 29 Supplement 2 p. S42-
1 p.
 artikel
179 Risk for medical personnel handling antineoplastic drugs Milković-Kraus, S
 1993
 29 Supplement 2 p. S124-
1 p.
 artikel
180 Role of interleukin-2 in regulating lymphocyte activation and recirculation Fortis, Claudio
 1993
 29 Supplement 2 p. 474-475
2 p.
 artikel
181 Routine telephone contact is not justified for support of patients completing radiotherapy: Results from a randomized controlled trial Munro, AJ
 1993
 29 Supplement 2 p. S214-
1 p.
 artikel
182 Scheduling of ultra low dose interleukin-2 in immunotherapy Lindemann, Albrecht
 1993
 29 Supplement 2 p. 2336-
1 p.
 artikel
183 Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide Anderson, Elizabeth
 1993
 29 Supplement 2 p. 209-217
9 p.
 artikel
184 Sexual dysfunctions among cancer patients Estapé, T
 1993
 29 Supplement 2 p. S213-
1 p.
 artikel
185 Single-dose antibiotic prophylaxis with teicoplanin in cancer patients receiving continuous infusion interleukin-2 through central venous catheter Corti, C
 1993
 29 Supplement 2 p. S50-
1 p.
 artikel
186 Small cell lung cancer and CNS-metastases — Results of combination chemotherapy with carboplatin/etoposide/vincristine (CEV) Heitmann, U.
 1993
 29 Supplement 2 p. S155-
1 p.
 artikel
187 Small round blue cell malignant tumors of soft tissues and bone in adult patients Casali, P
 1993
 29 Supplement 2 p. S182-
1 p.
 artikel
188 Soluble IL-2 receptor levels in breast cancer - clinical application Burde, B.
 1993
 29 Supplement 2 p. S249-
1 p.
 artikel
189 Somatic point mutation in the HER-2 cene sequence coddig for the transmembrane region associated with high serum concentrations of p185 fragments in human breast cancer Kynast, B.
 1993
 29 Supplement 2 p. S195-
1 p.
 artikel
190 Splenic abscess: A rare surgical emergency observed during induction of acute lymphocytic leukemia (ALL) therapy Cecchetto, G.
 1993
 29 Supplement 2 p. S199-
1 p.
 artikel
191 Spontaneous variations of IFN-g and RIL-2 sera concentrations, during 8 hours in advanced mal I gnant melanoma cancer patients Cupissol, D.
 1993
 29 Supplement 2 p. S50-
1 p.
 artikel
192 Study of 2 doses of granulocyte colony stimulating factor (G-CSF): PE 2601 in patients (PTS) with advanced breast carcinoma (ABC) treated by intensive chemotherapy Fumoleau, P.
 1993
 29 Supplement 2 p. S83-
1 p.
 artikel
193 Study of the role of breast self-examination in the reduction of mortality from breast cancer The Russian Federation/World Health Organization Study,
 1993
 29 Supplement 2 p. 2039-2046
8 p.
 artikel
194 Subcutaneous implantable infusional devices in oncologic pediatric patients Armiraglio, M
 1993
 29 Supplement 2 p. S257-
1 p.
 artikel
195 Successful therapy in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine (2CdA) - single institute experience Dann, E.J.
 1993
 29 Supplement 2 p. S153-
1 p.
 artikel
196 Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy Friedl, Andreas
 1993
 29 Supplement 2 p. 1368-1372
5 p.
 artikel
197 Surgical resection plus tamoxifen as treatment of breast cancer in elderly patients: a retrospective study Martelli, Gabriele
 1993
 29 Supplement 2 p. 2080-2082
3 p.
 artikel
198 Surveillance following orchidectomy for stage I seminoma of the testis von der Maase, Hans
 1993
 29 Supplement 2 p. 1931-1934
4 p.
 artikel
199 Taxol® metabolism in human plasma Huizing, M.T
 1993
 29 Supplement 2 p. S108-
1 p.
 artikel
200 Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours O'Reilly, S.M.
 1993
 29 Supplement 2 p. 940-942
3 p.
 artikel
201 The Economic Impact of 5-HT3 Receptor Antagonists Cunningham, K.
 1993
 29 Supplement 2 p. 930-
1 p.
 artikel
202 The function of lytic granules in tumor therapy induced by IL-2 activated killer lymphocytes Berke, G.
 1993
 29 Supplement 2 p. S15-
1 p.
 artikel
203 The immunohistochemical expression of proliferating cell nuclear antigen (PCNA/cyclin) in malignant and benign epithelial ovarian neoplasms and correlation with prognosis Nakopoulou, L
 1993
 29 Supplement 2 p. 1599-1601
3 p.
 artikel
204 The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s Cold, Søren
 1993
 29 Supplement 2 p. 1146-1152
7 p.
 artikel
205 The management of radiation-associated oesophageal carcinoma: a report of 16 cases Taal, B.G.
 1993
 29 Supplement 2 p. 1114-1119
6 p.
 artikel
206 The prognostic role of histological grade and c-erbB-2 oncogene amplification in primary tumors of metastatic breast cancer Niskanen, E.
 1993
 29 Supplement 2 p. S82-
1 p.
 artikel
207 The rearrangement of BCL-2 gene in Chinese cases of follicular lymphoma Po-min, Chen
 1993
 29 Supplement 2 p. S175-
1 p.
 artikel
208 The therapeutic challenge of gliomas McVie, J.G.
 1993
 29 Supplement 2 p. 936-939
4 p.
 artikel
209 The value of twice yearly bronchoscopy in the work-up and follow-up of patients with laryngeal cancer Rachmat, L.
 1993
 29 Supplement 2 p. 1096-1099
4 p.
 artikel
210 Three arms randomized trial comparing methoirexaie, 5-FU and leucovorin (MFL) vs 5-FU, leucovorin (FL) vs 5-FU (F) in advanced and meiasiatic colorectal cancer. (final results) Abed, A.
 1993
 29 Supplement 2 p. S89-
1 p.
 artikel
211 Thyroid cancer in children in Norway 1953–1987 Thoresen, Steinar
 1993
 29 Supplement 2 p. 365-366
2 p.
 artikel
212 Thyroid cancer in suppressed contralateral lobe of patients with hot thyroid nodule Satta, M.A.
 1993
 29 Supplement 2 p. 1190-1192
3 p.
 artikel
213 Tissue concentrations of prothymosin alpha: A novel proliferation index of primary breast cancer Dominguez, Fernando
 1993
 29 Supplement 2 p. 893-897
5 p.
 artikel
214 Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator Gion, Massimo
 1993
 29 Supplement 2 p. 66-69
4 p.
 artikel
215 Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell lines Harstrick, A.
 1993
 29 Supplement 2 p. 1000-1002
3 p.
 artikel
216 Treatment of melphalan-resistant multiple myeloma with vincristine, BCNU, doxorubicin, and high-dose dexamethasone (VBAD) Bladé, Joan
 1993
 29 Supplement 2 p. 57-60
4 p.
 artikel
217 Trends in lung cancer mortality in three broad Italian geographical areas between 1969 and 1987 Capocaccia, Riccardo
 1993
 29 Supplement 2 p. 1288-1293
6 p.
 artikel
218 Tumor markers — Diagnostic significance in lung cancer Garanina, Z.
 1993
 29 Supplement 2 p. S245-
1 p.
 artikel
219 Tumour necrosis factor increases tumour uptake of Co-administered antibody-carboxypeptidase G2 conjugate Melton, R.G.
 1993
 29 Supplement 2 p. 1177-1183
7 p.
 artikel
220 Tumour necrosis factor-α plasma levels after flavone acetic acid administration in man and mouse Chabot, G.G.
 1993
 29 Supplement 2 p. 729-733
5 p.
 artikel
221 Two dose levels of epirubicin in combination with cis platinum and vincristine /PEV/ in the treatment of small cell lung cancer /SCLC/ — Results of a controlled study Kolarić, K.
 1993
 29 Supplement 2 p. S153-
1 p.
 artikel
222 Types of cyclic AMP binding proteins in human breast cancers Miller, W.R.
 1993
 29 Supplement 2 p. 989-991
3 p.
 artikel
223 U.K. DCIS trial—Time for review? Thornton, Hazel
 1993
 29 Supplement 2 p. 428-429
2 p.
 artikel
224 Verapamil enhances doxorubicin activity in cultured human renal carcinoma cells Lai, Teresa
 1993
 29 Supplement 2 p. 378-383
6 p.
 artikel
225 Vinca alkaloids: Anti-vascular effects in a murine tumour Hill, S.A.
 1993
 29 Supplement 2 p. 1320-1324
5 p.
 artikel
226 Weekly carboplatin (CARBO) plus chronic oral etoposide (VP-16) as first line therapy in small cell lung cancer (SCLC). A phase II trial Palombo, H
 1993
 29 Supplement 2 p. S156-
1 p.
 artikel
227 Zn-α 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters Díez-Itza, Irene
 1993
 29 Supplement 2 p. 1256-1260
5 p.
 artikel
                             227 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland